Home >> Research Area >>Others>>MDR multidrug resistance>> Pyronaridine Tetraphosphate

Pyronaridine Tetraphosphate

Antimalarial agent CAS# 76748-86-2

Pyronaridine Tetraphosphate

Catalog No. BCC1144----Order now to get a substantial discount!

Product Name & Size Price Stock
Pyronaridine Tetraphosphate: 5mg $6 In Stock
Pyronaridine Tetraphosphate: 10mg Please Inquire In Stock
Pyronaridine Tetraphosphate: 20mg Please Inquire Please Inquire
Pyronaridine Tetraphosphate: 50mg Please Inquire Please Inquire
Pyronaridine Tetraphosphate: 100mg Please Inquire Please Inquire
Pyronaridine Tetraphosphate: 200mg Please Inquire Please Inquire
Pyronaridine Tetraphosphate: 500mg Please Inquire Please Inquire
Pyronaridine Tetraphosphate: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of Pyronaridine Tetraphosphate

Number of papers citing our products

Chemical structure

Pyronaridine Tetraphosphate

3D structure

Chemical Properties of Pyronaridine Tetraphosphate

Cas No. 76748-86-2 SDF Download SDF
PubChem ID 5488630 Appearance Powder
Formula C29H32ClN5O24H3PO4 M.Wt 968.0
Type of Compound N/A Storage Desiccate at -20°C
Solubility DMSO : 25 mg/mL (27.47 mM; Need ultrasonic and warming)
Chemical Name 4-[(7-chloro-2-methoxy-1,5-dihydrobenzo[b][1,5]naphthyridin-10-yl)imino]-2,6-bis(pyrrolidin-1-ylmethyl)cyclohexa-2,5-dien-1-one;phosphoric acid
SMILES COC1=CC=C2C(=C(C3=C(N2)C=C(C=C3)Cl)N=C4C=C(C(=O)C(=C4)CN5CCCC5)CN6CCCC6)N1.OP(=O)(O)O.OP(=O)(O)O.OP(=O)(O)O.OP(=O)(O)O
Standard InChIKey JDVZOLDKAQEQDD-UHFFFAOYSA-N
Standard InChI InChI=1S/C29H32ClN5O2.4H3O4P/c1-37-26-9-8-24-28(33-26)27(23-7-6-21(30)16-25(23)32-24)31-22-14-19(17-34-10-2-3-11-34)29(36)20(15-22)18-35-12-4-5-13-35;4*1-5(2,3)4/h6-9,14-16,32-33H,2-5,10-13,17-18H2,1H3;4*(H3,1,2,3,4)
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of Pyronaridine Tetraphosphate

DescriptionPyronaridine Tetraphosphate is a common antimalarial agent.
TargetsMDR multidrug resistance    

Pyronaridine Tetraphosphate Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Pyronaridine Tetraphosphate Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Pyronaridine Tetraphosphate

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 1.0331 mL 5.1653 mL 10.3306 mL 20.6612 mL 25.8264 mL
5 mM 0.2066 mL 1.0331 mL 2.0661 mL 4.1322 mL 5.1653 mL
10 mM 0.1033 mL 0.5165 mL 1.0331 mL 2.0661 mL 2.5826 mL
50 mM 0.0207 mL 0.1033 mL 0.2066 mL 0.4132 mL 0.5165 mL
100 mM 0.0103 mL 0.0517 mL 0.1033 mL 0.2066 mL 0.2583 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Research Update of Pyronaridine Tetraphosphate

1. Absorption, distribution, excretion, and pharmacokinetics of 14C-pyronaridine tetraphosphate in male and female Sprague-Dawley rats. J Biomed Biotechnol. 2010;2010:590707. doi: 10.1155/2010/590707. Epub 2010 Mar 31.
Abstract
PNDP, an antimalarial drug, could barely cross the blood-brain barrier and exhibited gender-independent pharmacokinetics where orally administered PNDP was readily absorbed from the small intestine, widely distributed in tissues and excreted in urine, feces and breath with similar values of C(max), AUC(0-inf) and T(max) to those in previous studies.
2. Determination of the physicochemical properties of pyronaridine - a new antimalarial drug. Pak J Pharm Sci. 2006 Jan;19(1):1-6.
Abstract
Pyronaridine tetraphosphate is a water-soluble tetraphosphate salt of pyronaridine, an antimalarial drug, and has significant light absorption in the range of 190-380 nm.
3. Improved assay method for the determination of pyronaridine in plasma and whole blood by high-performance liquid chromatography for application to clinical pharmacokinetic studies. J Chromatogr B Biomed Sci Appl. 2001 Mar 5;752(1):39-46.
Abstract
Plasma and blood specimens from a rabbit pretreated with pyronnaridine tetraphosphate were analyzed by a high-performance liquid chromatography method.
4. Analysis of blood and urine samples from Macaca mulata for pyronaridine by high-performance liquid chromatography with electrochemical detection. J Chromatogr. 1990 Apr 27;527(1):115-26.
Abstract
Blood and urine samples from a monkey pretreated with pyronaridine tetraphosphate were analyzed by a high-performance liquid chromatographic method.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on Pyronaridine Tetraphosphate

Pyronaridine (PND), a synthetic quinolone derivative frequently prescribed for the treatment of malaria, is a selective and potent multidrug resistance (MDR) modulator of Pgp-mediated MDR that inhibits the proliferation of a variety of tumor cells, including myeloid leukemia (K562 and K562/A02), epidermoid carcinoma (KB and KBV200), breast carcinoma (MCF-7 and MCF-7/ADR), ovarian carcinoma (SKOV3, ES-2 and PA-1), gastric carcinoma (BGC-823), colon carcinoma (LoVo), hepatocellular carcinoma (SMMZ-7721 and QGY-7703), with the half maximal inhibition concentration IC50 values of 8.3 μM, 5.6 μM, 20.8 μM, 14.5 μM, 9.5 μM, 11 μM, 9.7 μM, 12.9 μM, 15.7 μM, 14.9 μM, 21.4 μM, 10.9 μM and 17.1 μM respectively [1].

References:
[1] Qi J, Wang S, Liu G, Peng H, Wang J, Zhu Z, Yang C. Pyronaridine, a novel modulator of P-glycoprotein-mediated multidrug resistance in tumor cells in vitro and in vivo. Biochem Biophys Res Commun. 2004 Jul 9;319(4):1124-31.

Featured Products
New Products
 

References on Pyronaridine Tetraphosphate

Absorption, distribution, excretion, and pharmacokinetics of 14C-pyronaridine tetraphosphate in male and female Sprague-Dawley rats.[Pubmed:20379367]

J Biomed Biotechnol. 2010;2010:590707.

The main objective of this investigation was to determine the absorption, distribution, excretion, and pharmacokinetics of the antimalarial drug Pyronaridine Tetraphosphate (PNDP) in Sprague-Dawley rats. Following oral administration of a single dose (10 mg/Kg) of 14C-PNDP, it was observed that the drug was readily absorbed from the small intestine within 1 hour following oral administration and was widely distributed in most of the tissues investigated as determined from the observed radioactivity in the tissues. The peak value of the drug in the blood was reached at around 8 hours postadministration, and radioactivity was detected in most of the tissues from 4 hours onwards. 14C-PNDP showed a poor permeability across the blood-brain barrier, and the absorption, distribution, and excretion of 14C-PNDP were found to be gender-independent as both male and female rats showed a similar pattern of radioactivity. Excretion of the drug was predominantly through the urine with a peak excretion post 24 hours of administration. A small amount of the drug was also excreted in the feces and also in the breath. It was found that the C(max), AUC (0-inf), and T(max) values were similar to those observed in the Phase II clinical trials of pyronaridine/artesunate (Pyramax) conducted in Uganda.

Description

Pyronaridine tetraphosphate is a Mannich base anti-malarial with demonstrated efficacy against drug resistant Plasmodium falciparum, P. vivax, P. ovale and P. malariae.

Keywords:

Pyronaridine Tetraphosphate,76748-86-2,Natural Products,MDR multidrug resistance, buy Pyronaridine Tetraphosphate , Pyronaridine Tetraphosphate supplier , purchase Pyronaridine Tetraphosphate , Pyronaridine Tetraphosphate cost , Pyronaridine Tetraphosphate manufacturer , order Pyronaridine Tetraphosphate , high purity Pyronaridine Tetraphosphate

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: